Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial

2015163 citationsJournal Articlehybrid Open Access

Authors

B Ndiaye · Hôpital Aristide Le Dantec

Friedrich Thienemann · University of Cape Town

Martin O. C. Ota · MRC Unit the Gambia

Bernard Landry · Aeras

Makhtar Camara · Hôpital Aristide Le Dantec

Siry Dièye · Hôpital Aristide Le Dantec

Tandakha Ndiaye Dièye ·

Abstract

European & Developing Countries Clinical Trials Partnership (IP.2007.32080.002), Aeras, Bill & Melinda Gates Foundation, Wellcome Trust, and Oxford-Emergent Tuberculosis Consortium.

Topics & Keywords

Tuberculosis Research and Epidemiology HIV Research and Treatment Pneumocystis jirovecii pneumonia detection and treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Lancet Respiratory Medicine

Volume 3, Issue 3, pp. 190-200

DOI: 10.1016/s2213-2600(15)00037-5

Field-Weighted Citation Impact: 13.80